We are live on ! Find out more

2,478 hedge funds and large institutions have $147B invested in Merck in 2020 Q1 according to their latest regulatory filings, with 140 funds opening new positions, 1,117 increasing their positions, 969 reducing their positions, and 168 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more funds holding in top 10

Funds holding in top 10: 208243 (+35)

15% more repeat investments, than reductions

Existing positions increased: 1,117 | Existing positions reduced: 969

0% more call options, than puts

Call options by funds: $1.28B | Put options by funds: $1.28B

0.2% less ownership

Funds ownership: 79.29%79.09% (-0.2%)

2% less funds holding

Funds holding: 2,5372,478 (-59)

16% less capital invested

Capital invested by funds: $175B → $147B (-$28.3B)

17% less first-time investments, than exits

New positions opened: 140 | Existing positions closed: 168

Holders
2,478
Holders Change
-59
Holders Change %
-2.33%
% of All Funds
54.59%
Holding in Top 10
243
Holding in Top 10 Change
+35
Holding in Top 10 Change %
+16.83%
% of All Funds
5.35%
New
140
Increased
1,117
Reduced
969
Closed
168
Calls
$1.28B
Puts
$1.28B
Net Calls
+$2.3M
Net Calls Change
+$361M
Name Holding Trade Value Shares
Change
Change in
Stake
WAMC
2476
Western Asset Management Company
California
$2K +$1.57K +20 New
WAS
2477
Winch Advisory Services
Wisconsin
$2K +$2.04K +26 New
WA
2478
WBH Advisory
Maryland
$1.79K -$5.03K -64 -0.3%
NL
2479
NWAM LLC
Washington
$1.16K +$250K +3,187 +25%
TFA
2480
Transamerica Financial Advisors
Florida
$1K
CCT
2481
Capital City Trust
Florida
$292 +$312K +3,966 New
WIM
2482
Westside Investment Management
California
$210 +$225K +2,864 New
Point72 Asset Management
2483
Point72 Asset Management
Connecticut
-$51.2M -590,054 Closed
HM
2484
HealthCor Management
New York
-$48.5M -558,804 Closed
Holocene Advisors
2485
Holocene Advisors
New York
-$36.1M -415,728 Closed
RA
2486
Rovida Advisors
Florida
-$28.8M -332,216 Closed
A
2487
AustralianSuper
Australia
-$25.3M -291,837 Closed
CM
2488
Castleark Management
Illinois
-$21.3M -245,798 Closed
Balyasny Asset Management
2489
Balyasny Asset Management
Illinois
-$20.1M -231,956 Closed
TAM
2490
Todd Asset Management
Kentucky
-$16.9M -194,945 Closed
SCM
2491
Stevens Capital Management
Pennsylvania
-$15.7M -181,297 Closed
OAC
2492
OMERS Administration Corp
Ontario, Canada
-$12.7M -146,720 Closed
DBG
2493
De Burlo Group
Massachusetts
-$12.1M -138,860 Closed
Capstone Investment Advisors
2494
Capstone Investment Advisors
New York
-$10M -127,748 Closed
BCM
2495
Bluefin Capital Management
New York
-$10.6M -121,908 Closed
NLGIA
2496
Nippon Life Global Investors Americas
New York
-$10.5M -121,222 Closed
CCI
2497
Columbus Circle Investors
-$10.2M -117,491 Closed
PMAM
2498
Picton Mahoney Asset Management
Ontario, Canada
-$9.33M -107,446 Closed
WI
2499
WBI Investments
New Jersey
-$7.82M -90,053 Closed
Qube Research & Technologies (QRT)
2500
Qube Research & Technologies (QRT)
United Kingdom
-$6.88M -79,241 Closed

MRK Hedge Fund Activity: Q1 2020 in Review

2,478 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q1 2020, worth a combined $147B — down 16% from $175B a quarter earlier.

Sellers outnumbered buyers: 168 funds closed out of MRK and 140 opened new positions — a net loss of 28 holders — while 969 trimmed existing stakes and 1,117 added.

The largest buyer was Massachusetts Financial Services, adding an estimated $552M. The largest seller was Capital World Investors, cutting an estimated $1.94B.

  • 2,478 institutional investors held Merck (MRK) as of Q1 2020, down from 2,537 in Q4 2019.
  • Funds reported $147B of Merck stock for Q1 2020, down 16% quarter-over-quarter.
  • 140 funds opened new Merck positions in Q1 2020 and 168 closed out, a net change of -28 holders.
  • The largest Merck buyer in Q1 2020 was Massachusetts Financial Services, an estimated $552M added.
  • The largest Merck seller in Q1 2020 was Capital World Investors, an estimated $1.94B sold.

Based on aggregated 13F filings for Q1 2020.